NO821288L - Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazol- og imidazolin-derivater - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazol- og imidazolin-derivaterInfo
- Publication number
- NO821288L NO821288L NO821288A NO821288A NO821288L NO 821288 L NO821288 L NO 821288L NO 821288 A NO821288 A NO 821288A NO 821288 A NO821288 A NO 821288A NO 821288 L NO821288 L NO 821288L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- therapeutic active
- imidazoline derivatives
- active imidazole
- analogue procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
- C07D233/08—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms with alkyl radicals, containing more than four carbon atoms, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8112506A GB2096987B (en) | 1981-04-22 | 1981-04-22 | Substituted imidazole and imidazole derivatives and their preparation and use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO821288L true NO821288L (no) | 1982-10-25 |
Family
ID=10521291
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO821288A NO821288L (no) | 1981-04-22 | 1982-04-21 | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazol- og imidazolin-derivater |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0064820A1 (de) |
| JP (1) | JPS57181063A (de) |
| AU (1) | AU8223082A (de) |
| CA (1) | CA1183544A (de) |
| DD (1) | DD207375A1 (de) |
| DK (1) | DK174782A (de) |
| FI (1) | FI821316L (de) |
| GB (1) | GB2096987B (de) |
| NO (1) | NO821288L (de) |
| ZA (1) | ZA822346B (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4992459A (en) * | 1983-04-12 | 1991-02-12 | Smithkline Beecham Corporation | Dopamine-β-hydroxylase inhibitors |
| US4532331A (en) * | 1983-04-12 | 1985-07-30 | Smithkline Beckman Corporation | 1-Benzyl-2-aminomethyl imidazole derivatives |
| DE3428342A1 (de) * | 1984-08-01 | 1986-02-13 | Boehringer Ingelheim Vetmedica GmbH, 6507 Ingelheim | Futtermittelzusatz zur verbesserung des wachstums bei landwirtschaftlichen nutztieren |
| FI844786A0 (fi) * | 1984-12-04 | 1984-12-04 | Farmos Oy | Terapeutiskt utnyttjbar foerening. |
| US4634711A (en) * | 1985-08-02 | 1987-01-06 | Smithkline Beckman Corporation | Pyridylalkyl imidazole-2-thiols |
| US4719223A (en) * | 1985-10-31 | 1988-01-12 | Smithkline Beckman Corporation | Imidazolethiol dopamine-beta-hydroxylase inhibitors |
| US4743613A (en) * | 1986-04-08 | 1988-05-10 | Smithkline Beckman Corporation | Ester prodrugs of dopamine-β-hydroxylase, inhibitors, composition containing them, and method of using them to inhibit dopamine-β-hydroxylase activity |
| GB2210875B (en) * | 1987-10-09 | 1991-05-29 | Farmos Oy | Aromatase inhibiting 4(5)-imidazoles |
| US4876266A (en) * | 1987-12-31 | 1989-10-24 | Smithkline Beckman Corporation | 1-aralkyl-2-mercaptoimidazolines as DBH inhibitors |
| DE68917897D1 (de) * | 1988-12-15 | 1994-10-06 | Texaco Development Corp | Verfahren zur Herstellung von Imidazolen. |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3050520A (en) * | 1960-03-31 | 1962-08-21 | Air Prod & Chem | Process of preparing 2-olefinic imidazoles |
| US3502661A (en) * | 1967-02-14 | 1970-03-24 | Pfizer & Co C | Process for making 1,4,5,6-tetrahydro-2-((2-substituted)vinyl) pyrimidines and 2-((2-substituted)vinyl)-2-imidazolines |
| IL39413A0 (en) * | 1971-05-13 | 1972-07-26 | Sparamedica Ag | Benzodiazepine derivatives,their preparation and pharmaceutical compositions containing them |
| BE793407A (fr) * | 1971-12-28 | 1973-06-28 | Hoechst Ag | Imidazolyl - (2) -carbinols ayant une activite hypolipidemique et leur procede de preparation |
| DE2623377A1 (de) * | 1975-05-30 | 1976-12-09 | Scherico Ltd | 2-imidazoline und ihre anwendung in pharmazeutischen zubereitungen sowie verfahren zu ihrer herstellung |
-
1981
- 1981-04-22 GB GB8112506A patent/GB2096987B/en not_active Expired
-
1982
- 1982-03-31 AU AU82230/82A patent/AU8223082A/en not_active Abandoned
- 1982-03-31 CA CA000400252A patent/CA1183544A/en not_active Expired
- 1982-04-05 ZA ZA822346A patent/ZA822346B/xx unknown
- 1982-04-15 FI FI821316A patent/FI821316L/fi not_active Application Discontinuation
- 1982-04-16 EP EP82301971A patent/EP0064820A1/de not_active Ceased
- 1982-04-17 JP JP57064613A patent/JPS57181063A/ja active Pending
- 1982-04-19 DD DD82239105A patent/DD207375A1/de unknown
- 1982-04-20 DK DK174782A patent/DK174782A/da not_active Application Discontinuation
- 1982-04-21 NO NO821288A patent/NO821288L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK174782A (da) | 1982-10-23 |
| FI821316A0 (fi) | 1982-04-15 |
| FI821316A7 (fi) | 1982-10-23 |
| FI821316L (fi) | 1982-10-23 |
| CA1183544A (en) | 1985-03-05 |
| GB2096987A (en) | 1982-10-27 |
| GB2096987B (en) | 1984-04-04 |
| JPS57181063A (en) | 1982-11-08 |
| DD207375A1 (de) | 1984-02-29 |
| ZA822346B (en) | 1983-03-30 |
| AU8223082A (en) | 1982-10-28 |
| EP0064820A1 (de) | 1982-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO821645L (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive benzoazepinderivater | |
| NO841568L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive fenetanolamin-derivater | |
| NO156785C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklobutan-derivater. | |
| NO164025C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-imidazolylmetyl-tetrahydrokarbazolon-derivater. | |
| NO820479L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive carbostyrilderivater | |
| NO853293L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater. | |
| NO843979L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater | |
| NO851695L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 2-(n-substituert-guanidino)-4-heteroaryl-tiazol-derivater | |
| NO161497C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 9a-aza-9a-homoerytromycin-derivater. | |
| NO157296C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n-(4-indolyl-piperidino-alkyl)-benzimidazolon-derivater. | |
| NO852729L (no) | Fremgangsmaate for fremstilling av terapeutisk virksomme benzimidazol- og benzotiazolderivater | |
| NO891293D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive imidazol - og triazol-derivater. | |
| NO843084L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive adenosin-derivater | |
| NO841542L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater | |
| NO854369L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive benzimidazol-derivater | |
| NO172849C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazol- og oksazol-derivater | |
| NO893909L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive imidazol-derivater. | |
| NO155771C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aminopropanolderivater. | |
| NO821288L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazol- og imidazolin-derivater | |
| NO833527L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklobutylderivater | |
| NO820112L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater | |
| NO170085C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive (benzofuran-2-yl)imidazoler | |
| NO843377L (no) | Fremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater | |
| NO821882L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolo-pyrido-diazepin-derivater | |
| NO813263L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinolon-derivater |